Michael Angelo
Family Medicine · Bossier City, LANPI 1295723955
Payments from drug & device makers
Across 586 payments — averaging $25.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$3K
- AbbVie$2K
- Amgen$2K
- Lilly USA, LLC$948
- Takeda Pharmaceuticals U.S.A., Inc.$558
- Esperion Therapeutics, Inc.$547
- plus $7K from 51 others
Across 1 payment — averaging $100.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Atland Pharmaceuticals, LLC$100
What the payments were for
- Food & beverage$15,10499%
- Education$1061%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$15,210 in reported general payments places this provider in the 95th percentile of 1,469 family medicine providers in Louisiana.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 321 | $101,948 |
| MounjaroTirzepatide | 82 | $72,103 |
| FarxigaDapagliflozin Propanediol | 93 | $50,083 |
| GemtesaVibegron | 152 | $46,019 |
| NuedextaDextromethorphan Hbr/Quinidine | 59 | $36,944 |
| JardianceEmpagliflozin | 80 | $33,185 |
| XareltoRivaroxaban | 91 | $25,493 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 38 | $25,340 |
| EntrestoSacubitril/Valsartan | 28 | $19,191 |
| RexultiBrexpiprazole | 25 | $18,838 |
| JanuviaSitagliptin Phosphate | 63 | $18,082 |
| OzempicSemaglutide | 16 | $17,273 |
| KerendiaFinerenone | 20 | $16,467 |
| LinzessLinaclotide | 18 | $12,135 |
| JanumetSitagliptin Phos/Metformin Hcl | 32 | $11,211 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $380 | $101,948321 claims |
| Lilly USA, LLCMounjaro, Trulicity | $948 | $81,998102 claims |
| AstraZenecaFarxiga, Brilinta, Lokelma | $2,527 | $65,320147 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $87 | $46,019152 claims |
| Avanir Pharmaceuticals, Inc.Nuedexta | $31 | $36,94459 claims |
| Boehringer IngelheimJardiance | $402 | $33,18580 claims |
| MerckJanuvia, Janumet | $188 | $29,29295 claims |
| Johnson & JohnsonXarelto | $125 | $25,49391 claims |
| GSKTrelegy Ellipta | $476 | $25,34038 claims |
| AbbVieLinzess, Restasis | $1,825 | $19,57429 claims |
| NovartisEntresto | $99 | $19,19128 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $383 | $18,83825 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 1,469 family medicine providers in Louisiana.
Other family medicine in Bossier City
- Clint WilsonBossier City$208K
- Jason MilliganBossier City$15K
- Clinton GuilloryMonroe$18.5M
- Jason MorrisLake Charles$18M
- Michael SeepLake Charles$9.1M
- William NaboursLake Charles$3M
- Ramon VargasKenner$2.1M
- Stephen JonesNew Orleans$513K
- Joshua WhatleyLake Charles$366K
- Richard JeansonneMandeville$362K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.